- Filed
- Mar 11, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jan 31, 2025 | 59.43M sh |
| Long Term Debt | Q2 2025 · Jan 31, 2025 | $134.74K |
| Long Term Debt | Q2 2025 · Jul 31, 2024 | $131.84K |
| Cash And Equivalents | Q2 2025 · Jan 31, 2025 | $200 |
| Cash And Equivalents | Q2 2025 · Jul 31, 2024 | $12.05K |
| Current Liabilities | Q2 2025 · Jan 31, 2025 | $546.42K |
| Current Liabilities | Q2 2025 · Jul 31, 2024 | $418.9K |
| Total Liabilities | Q2 2025 · Jan 31, 2025 | $679.96K |
| Total Liabilities | Q2 2025 · Jul 31, 2024 | $664.8K |
| Current Assets | Q2 2025 · Jan 31, 2025 | $3.05K |
| Current Assets | Q2 2025 · Jul 31, 2024 | $17K |
| Total Assets | Q2 2025 · Jan 31, 2025 | $3.05K |
| Total Assets | Q2 2025 · Jul 31, 2024 | $17K |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 59.43M sh |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 59.43M sh |
| Stockholders Equity | Q2 2025 · Jan 31, 2024 | −$628.79K |
| Stockholders Equity | Q2 2025 · Oct 31, 2023 | −$602.78K |
| Stockholders Equity | Q2 2025 · Jul 31, 2023 | −$583.98K |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | −$0.00 |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | −$0.00 |
| Eps Basic | Q2 2025 · Jan 31, 2024 | −$0.00 |
| Eps Basic | Q2 2025 · Jan 31, 2024 | −$0.00 |
| Net Income | Q2 2025 · Jan 31, 2024 | −$18.99K |
| Net Income | Q2 2025 · Jan 31, 2024 | −$44.24K |